Low‐dose ponatinib is a good option in chronic myeloid leukemia patients intolerant to previous TKIs. Issue 10 (7th July 2020)

Record Type:: Journal Article
Title:: Low‐dose ponatinib is a good option in chronic myeloid leukemia patients intolerant to previous TKIs. Issue 10 (7th July 2020)
Main Title:: Low‐dose ponatinib is a good option in chronic myeloid leukemia patients intolerant to previous TKIs
Authors:: Iurlo, Alessandra
Cattaneo, Daniele
Malato, Alessandra
Accurso, Vincenzo
Annunziata, Mario
Gozzini, Antonella
Scortechini, Anna Rita
Bucelli, Cristina
Scalzulli, Emilia
Attolico, Imma
Maggi, Alessandro
Martino, Bruno
Caocci, Giovanni
Abruzzese, Elisabetta
Pregno, Patrizia
Luciano, Luigiana
Breccia, Massimo
Abstract:
Is Part Of:: American journal of hematology. Volume 95:Issue 10(2020:Oct.)
Journal:: American journal of hematology
Issue:: Volume 95:Issue 10(2020:Oct.)
Issue Display:: Volume 95, Issue 10 (2020)
Year:: 2020
Volume:: 95
Issue:: 10
Issue Sort Value:: 2020-0095-0010-0000
Page Start:: E260
Page End:: E263
Publication Date:: 2020-07-07
Subjects:: Hematology -- Periodicals
616.15
Journal URLs:: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1096-8652 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1002/ajh.25908 ↗
Languages:: English
ISSNs:: 0361-8609
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 0824.800000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 14308.xml